CBPO [China Biologic Products] 8-K: (Original Filing)

[FOR RELEASE August 5, 2014 China Biologic Reports Financial Results for the Second Quarter of 2014 2Q14 Total Sales Increase 12.1% to $60.1Million 2Q14 Operating Margin Increases to 48.1% from 2Q14 Non-GAAP Net Income Increases 17.9% to $20.5 Million BEIJING, China – August 5, 2014 – Second Quarter 2014 Financial Highlights · Total sales · Gross profit · Income from] []

CBPO [China Biologic Products] 8-K: FOR RELEASE August 5, 2014 China Biologic Reports

[FOR RELEASE August 5, 2014 China Biologic Reports Financial Results for the Second Quarter of 2014 2Q14 Total Sales Increase 12.1% to $60.1Million 2Q14 Operating Margin Increases to 48.1% from 2Q14 Non-GAAP Net Income Increases 17.9% to $20.5 Million BEIJING, China – August 5, 2014 – Second Quarter 2014 Financial Highlights · Total sales · Gross profit · Income from] []

CBPO [China Biologic Products] 10-Q: (Original Filing)

[] [STATE OF DELAWARE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CHINA BIOLOGIC PRODUCTS, INC. Corporation China Biologic Products, Inc., a corporation organized and existing under the laws of the State of Delaware (the “ A. The name of the Corporation is China Biologic Products, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of] [THIRD AMENDED AND RESTATED BYLAWS OF CHINA BIOLOGIC PRODUCTS, INC. (the “Corporation”) Adopted on June 20, 2014 ARTICLE I OFFICES Registered Office Certificate of Incorporation Section 1.01. Other Offices Board of Directors Board Section 1.02. ARTICLE II MEETINGS OF STOCKHOLDERS Annual Meeting Section 2.01. Voting List Section 2.02. Special Meeting Section 2.03. Advance Notice Procedures Section 2.04. Advance Notice of] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)]

CBPO [China Biologic Products] 10-Q:

[] [STATE OF DELAWARE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CHINA BIOLOGIC PRODUCTS, INC. Corporation China Biologic Products, Inc., a corporation organized and existing under the laws of the State of Delaware (the “ A. The name of the Corporation is China Biologic Products, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of] [THIRD AMENDED AND RESTATED BYLAWS OF CHINA BIOLOGIC PRODUCTS, INC. (the “Corporation”) Adopted on June 20, 2014 ARTICLE I OFFICES Registered Office Certificate of Incorporation Section 1.01. Other Offices Board of Directors Board Section 1.02. ARTICLE II MEETINGS OF STOCKHOLDERS Annual Meeting Section 2.01. Voting List Section 2.02. Special Meeting Section 2.03. Advance Notice Procedures Section 2.04. Advance Notice of] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)]

JKS [JinkoSolar] CORRESP: August 5, 2014 VIA EDGAR CORRESP Brian Cascio

[August 5, 2014 VIA EDGAR CORRESP Brian Cascio Gary Todd Kristin Lochhead Division of Corporation Finance 100 F Street, NE Re: JinkoSolar Holding Co., Ltd. Form 20-F for the fiscal year ended December 31, 2013 Filed April 18, 2014 File No. 001-34615 Dear Mr. Cascio, Mr. Todd and Ms. Lochhead: Staff Commission 20-F Company Reference is made to the letter]

By | 2016-03-27T07:08:05+00:00 August 5th, 2014|Categories: Chinese Stocks, JKS, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar